My Account
Logout

Patients Website

My Account
Logout

en-sa
- en-sa
- en-uae
- en-kw
- en-qa
- en-bh
- en-om

More Hide
en-sa
- en-sa
- en-uae
- en-kw
- en-qa
- en-bh
- en-om

My Account
Logout

Screening Solutions
CVRM
Oncology
Hematology
- Hematology
- AZ Hematology Hub
Respiratory
- Respiratory
- Breztri
Biologics
Vaccine & Immunology
- Vaccine & Immunology
- Covid 19
Rare Disease
Care corner
- Care corner

My Account
Logout

Screening Solutions
CVRM
Oncology
Hematology
- Hematology
- AZ Hematology Hub
Respiratory
- Respiratory
- Breztri
Biologics
Vaccine & Immunology
- Vaccine & Immunology
- Covid 19
Rare Disease
Care corner
- Care corner

AZ Hematology Hub

Featured Moments highlights of international experts' sessions captured in short videos.

Precision Approach for CLL Management

CLL Management in Clinic

Dr. Ruba Taha, Qatar

CLL Risk Stratification

Dr. Kostas Stamatopoulos, Greece

Optimizing CLL Management

Dr. Salem Alshemmari, Kuwait

Translating Data into Practice

Dr. Ayman Ibrahim, Saudi Arabia

Treatment Sequencing in R/R CLL

Dr. Ibrahim Al Nabanis

Translating Data Into Practise

Dr. Ramesh Pandita, Kuwait

01/03/2023

Lates Updates in Management of Non-Hodgkin Lymphoma

Dr. Alfadel AL Shaibani, KSA

01/03/2023

Precision approach for CLL treatment (26th June 2022)

Impact of Comorbidities and AEs on the Treatment Choice for CLL Patients

Dr. Ahmad Alhuraiji, Kuwait

01/03/2023

Watch Full Video

CLL Management in Clinic

Dr. Aamer Aleem, KSA

01/03/2023

Watch Full Video

How to Choose BTK Inhibitors for CLL Patients?

Dr. Krish Patel, US

01/03/2023

Watch Full Video

Translating Data Into Practice

Dr. Shabeeha Rana, UAE

01/03/2023

Watch Full Video

Panel Discussion

Dr. Amal Al-Beihany, KSA

01/03/2023

Watch Full Video

CLL Management in Clinic

Dr. Amar Lal, UAE

01/03/2023

Watch Full Video

Panel Discussion

Dr. Arif Alam, UAE

01/03/2023

Watch Full Video

Management of Treatment Naïve Mantle Cell Lymphoma

Dr. Mustaqeem Siddiqui, UAE

01/03/2023

Panel Discussion

Dr. Abdulaziz Hamadah, Kuwait

01/03/2023

Watch Full Video

Adverse Events burden and management in  CLL treatments (27th March 2022)

Optimizing the Usage of BTK Inhibitors in CLL

Dr. Cyrus Khan, US

01/03/2023

Watch Full Video

CLL Management Inside the Clinic

Dr. Hassan Aljasem, KSA

01/03/2023

Watch Full Video

Translating Data Into Practice

Dr. Husni Al Hateeti, UAE

01/03/2023

Watch Full Video

Burden of Comorbidities & Adverse Events in CLL

Dr. Musa Al Zahrani, KSA

01/03/2023

Watch Full Video

Panel Discussion

Dr. Amar Lal, UAE

01/03/2023

Watch Full Video

Evolving Landscape in MCL management

Updates in 1L MCL Management

Dr. Reyad Dada, Saudi Arabia

REQUEST A VISIT FROM AN AstraZeneca REPRESENTATIVE

Loading......

Thank you for visiting the AstraZeneca Medicines website

This link will take you to a website not owned by AstraZeneca. AstraZeneca provides this link as a service to our site visitors. AstraZeneca are not responsible for the content or privacy / legal policies of any third party websites.

Do you wish to continue?

Cancel Continue

Thank you for visiting the AstraZeneca Medicines website

Do you wish to continue?

Cancel Continue

Validating...

Disclaimer pop-up

Are you a licensed healthcare professional practicing in the UAE, KSA, Qatar, Kuwait, Oman, or Bahrain

AstraZeneca EduGate

This website is intended for doctors, nurses, and pharmacists in Gulf Countries. Others please visit www.astrazeneca.com.

Additional Info

Legal Notice and Terms of Use
Privacy Notice
Cookie Policy

Contact AstraZeneca

Contact Us
Report Adverse Event

Adverse events should be reported. Reporting forms and information can be found at aereporting.astrazeneca.com. Adverse events should also be reported to AstraZeneca Saudi on +966112249235 / email at ksa.ae@astrazeneca.com

في حالة وجود أي أعراض جانبیة للأدویة الرجاء التواصل مع الهیئة العامة للغذاء والدواء عن طریق الرقم الموحد 19999

Approval Code: Y1–1905

For Medical information Enquires
Website: https://contactazmedical.astrazeneca.com
E-mail: medinfo-ksa@astrazeneca.com

Al-Nakhla Tower - Floor 13th Ath Thumamah, Road - Al
Sahafa District. 7198 Unit No. 20 Riyadh 13315 – 3642.
Tel: +966 (011) 22 492 00
Fax: +966 (011) 22 492 91

Patients Website

AZ Hematology Hub

Precision Approach for CLL Management

CLL Management in Clinic

CLL Risk Stratification

Optimizing CLL Management

Translating Data into Practice

Treatment Sequencing in R/R CLL

Translating Data Into Practise

Lates Updates in Management of Non-Hodgkin Lymphoma

Precision approach for CLL treatment (26th June 2022)

Impact of Comorbidities and AEs on the Treatment Choice for CLL Patients

CLL Management in Clinic

How to Choose BTK Inhibitors for CLL Patients?

Translating Data Into Practice

Panel Discussion

CLL Management in Clinic

Panel Discussion

Management of Treatment Naïve Mantle Cell Lymphoma

Panel Discussion

Adverse Events burden and management in CLL treatments (27th March 2022)

Optimizing the Usage of BTK Inhibitors in CLL

CLL Management Inside the Clinic

Translating Data Into Practice

Burden of Comorbidities & Adverse Events in CLL

Panel Discussion

Evolving Landscape in MCL management

Updates in 1L MCL Management

Loading......

Loading......

Additional Info

Contact AstraZeneca

Adverse Events burden and management in  CLL treatments (27th March 2022)